Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 26, 2019
Patent Application Number
16137709
Date Filed
September 21, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Described herein are nanoparticle drug conjugates (NDCs), which, in certain embodiments, comprise a non-toxic, multi-modality, clinically proven silica-based nanoparticle platform with covalently attached drug molecules/moieties. The nanoparticle drug conjugates (NDCs) demonstrate imaging capability and targeting ligands which efficiently clear through the kidneys. Furthermore, the conjugates incorporate therapeutic agents for cancer detection, prevention, and/or treatment.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
